Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: Playtex

This article was originally published in The Tan Sheet

Executive Summary

Playtex: Looking to broaden OTC/H&BA portfolio through brand or company acquisitions, or by leveraging the Playtex name on new products in different categories, the company says. Hass, Wheat & Partners, which holds a 40% stake in Playtex, also is investigating strategic options for the company. The decision to further diversify may in part be a response to Procter & Gamble's April 9 announcement that it will acquire tampon category leader Tambrands. Playtex already is making headway in diversifying its revenue base -- for the first quarter of 1997, sun care (Banana Boat and BioSun) sales jumped 32.4% to $43.7 mil., representing 32% of the company's sales of $136.4 mil. The feminine care unit, on the other hand, slumped 32.7% to $39.1 mil., accounting for 28.7% of sales. In the year-earlier quarter, the segments represented 23.1% and 40.6% of sales, respectively...
Advertisement
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS087100

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel